The nuclear expression of the proliferation marker Ki-67 labeling index was significantly higher for ACC compared with ACA samples (23.5% (15–45 for ACC vs. 3% (1–5) for ACA (p = 0.001)) (Table 1, Figure 1C). The gene discussed is MKI67; the disease is adrenal cortex carcinoma.